Maeda T, Kitamura S, Yanagi T, Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.
Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.
Journal of Cutaneous Immunology and Allergy. 2019.
Maeda T, Kitamura S, Yanagi T, Narahira A, Miyamoto K, Hata H, Cho KY, Kameda H, Nakamura A, Shimizu H.
Type 1 diabetes mellitus in a melanoma patient treated with adjuvant nivolumab therapy.
Journal of Cutaneous Immunology and Allergy. 2019.
Metin-Armagan D, Comunoglu N, Bulut G, Kadioglu P, Kameda H, Gazioglu N, Tanriover N, Ozturk M.
A Novel Expression Profile of Cell Cycle and DNA Repair Proteins in Nonfunctioning Pituitary Adenomas
Endocrine Pathology. 2019. PMID: 31828584
Nomoto H, Montemurro C, Pei L, Rosenberger M, Furterer A, Coppola G, Nadel B, Pellegrini M, Gurlo T, Butler PC, Tudzarova S.
Activation of the HIF1α/PFKFB3 stress response pathway in beta-cells in type 1 diabetes.
Diabetologia. 2019. PMID: 31720731
Nomoto H, Gurlo T, Girgis M, Dry SM, Rosenberger M, Butler PC.
Low Grade Islet but Marked Exocrine Pancreas Inflammation in an Adult with Autoimmune Pre-Diabetes.
Case Reports in Endocrinology. 2019.
Cho KY, Nomoto H, Nakamura A, Kawata S, Sugawara H, Takeuchi J, Nagai S, Tsuchida K, Omori K, Yokoyama H, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Favourable effect of the sodium-glucose co-transporter-2 inhibitor canagliflozin plus the dipeptidyl peptidase-4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open-label, prospective, randomized, parallel-group comparison trial (the CALMER study).
Diabetes, Obesity and Metabolism. 2019. PMID: 31486230
Cho KY, Nakamura A, Oba-Yamamoto C, Tsuchida K, Yanagiya S, Manda N, Kurihara Y, Aoki S, Atsumi T, Miyoshi H.
Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial.
Diabetes & Metabolism Journal. 2019. PMID: 31769240
Montemurro C*, Nomoto H*, Pei L*, Vongbunyong KE, Vadrevu S, Gurlo T, Butler AE, Subramaniam R, Ritou E, Shirihai OS, Satin LS, Butler PC, Tudzarova S. IAPP toxicity activates HIF1α/PFKFB3 signaling delaying β-cell loss at the expense of β-cell function. Nat Commun. 2019. PMID: 31213603 (*: joint first authors)
Sekizaki T, Kameda H, Oba C, Cho KY, Nakamura A, Miyoshi H, Osawa T, Shinohara N, Atsumi T. Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. Endocr J, in press
Miya A, Nakamura A, Kameda H, Nozu K, Miyoshi H, Atsumi T. Gitelman’s Syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration: A case report. Medicine, in press
Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y. The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes. J Diabetes Investig in press. (PMID: 31026373)